KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ClearPoint Neuro (CLPT) Share-based Compensation (2018 - 2025)

ClearPoint Neuro (CLPT) has disclosed Share-based Compensation for 13 consecutive years, with $2.0 million as the latest value for Q4 2025.

  • Quarterly Share-based Compensation rose 16.32% to $2.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $8.2 million through Dec 2025, up 18.43% year-over-year, with the annual reading at $8.2 million for FY2025, 18.43% up from the prior year.
  • Share-based Compensation hit $2.0 million in Q4 2025 for ClearPoint Neuro, down from $2.0 million in the prior quarter.
  • In the past five years, Share-based Compensation ranged from a high of $2.3 million in Q2 2025 to a low of $247000.0 in Q2 2021.
  • Historically, Share-based Compensation has averaged $1.4 million across 5 years, with a median of $1.5 million in 2023.
  • Biggest five-year swings in Share-based Compensation: rose 2.49% in 2021 and later skyrocketed 256.28% in 2022.
  • Year by year, Share-based Compensation stood at $925000.0 in 2021, then increased by 26.7% to $1.2 million in 2022, then soared by 31.66% to $1.5 million in 2023, then grew by 10.37% to $1.7 million in 2024, then increased by 16.32% to $2.0 million in 2025.
  • Business Quant data shows Share-based Compensation for CLPT at $2.0 million in Q4 2025, $2.0 million in Q3 2025, and $2.3 million in Q2 2025.